Skip to main content
. 2019 Sep 15;200(6):751–759. doi: 10.1164/rccm.201812-2348OC

Table 1.

Characteristics and Outcomes of the Study Infants

Characteristic Full Study Cohort (N = 2,677)
Gestational age, wk, mean (SD) 25.2 (1.3)
 <27 wk, n (%) 2,380 (89)
 27 wk to 31 wk and 6 d, n (%) 297 (11)
Birth weight, g, mean (SD) 765 (168)
Sex, male, n (%) 1,356 (51)
Small for gestational age, n (%)* 219 (8)
Race, n (%)  
 Black 1,225 (46)
 White 1,312 (49)
 Other 140 (5)
Ethnicity, n (%)  
 Hispanic 322 (12)
 Non-Hispanic 2,355 (88)
Corrected age at follow-up, mo, mean (SD) 23.3 (3.0)
 Follow-up at 18–22 mo corrected age, n (%) 719 (28)
 Follow-up at 22–26 mo corrected age, n (%) 1,849 (72)
Antenatal corticosteroids, n (%) 2,397 (90)
Antenatal magnesium, n (%) 2,077 (78)
Maternal marital status, married, n (%) 1,126 (42)
Insurance type, n (%)  
 Medicaid 1,528 (57)
 Private 1,012 (38)
 Self-pay/uninsured 101 (4)
 Other 36 (1)
Maternal level of education less than high school, n (%) 499 (19)
Outcome  
 Late death or serious respiratory morbidity, n (%) 683 (26)
 Late death or moderate to severe NDI, n (%) 1,305 (49)

Definition of abbreviation: NDI = neurodevelopmental impairment.

*

Defined as a birth weight below the 10th percentile for gestational age and sex (25).

Calculated for the 2,568 infants who survived to follow-up testing.